The Upper Nasal Space as a Promising New Route for Drug Administration : Implications for Nasal Safety Assessments From the Pivotal STOP 301 Study of INP104

Greg Davis; Seth M. Pransky; Adil Fatakia; Stephen B. Shrewsbury *

doi:10.47739/2379-948X/1303

The Upper Nasal Space as a Promising New Route for Drug Administration : Implications for Nasal Safety Assessments From the Pivotal STOP 301 Study of INP104

Research Article | Open Access

Article DOI : https://doi.org/10.47739/2379-948X/1303

Greg Davis¹ Seth M. Pransky² Adil Fatakia³ Stephen B. Shrewsbury *⁴

^1. Proliance Surgeons, Seattle, WA
^2. Pediatric Specialty Partners, San Diego, CA
^3. New Orleans Sinus Center, New Orleans, LA
^4. Impel Pharmaceuticals, Seattle, WA

+ Show More - Show Less

Corresponding Authors

Stephen B. Shrewsbury, Impel Pharmaceuticals, 201 Elliott Avenue W., Ste. 260 | Seattle, WA 98119, Tel: +1-206-568-1466, Email: sshrewsbury@impelpharma.com

Annals of Otolaryngology and Rhinology

Annals of Otolaryngology and Rhinology

Annals of Otolaryngology and Rhinology

The Upper Nasal Space as a Promising New Route for Drug Administration : Implications for Nasal Safety Assessments From the Pivotal STOP 301 Study of INP104

Journals

JSciMed

Journals

The Upper Nasal Space as a Promising New Route for Drug Administration : Implications for Nasal Safety Assessments From the Pivotal STOP 301 Study of INP104

Journals

Subscribe to Newsletters